{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:08:35Z","timestamp":1794532115665,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth fund of National Natural Science Foundation of China","award":["82201406"],"award-info":[{"award-number":["82201406"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171421, 82371432, 92249302"],"award-info":[{"award-number":["82171421, 82371432, 92249302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health Commission of China","award":["Pro20211231084249000238"],"award-info":[{"award-number":["Pro20211231084249000238"]}]},{"name":"National Science and Technology Innovation 2030 Major Program","award":["2025ZD0217201"],"award-info":[{"award-number":["2025ZD0217201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01187-6","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T19:04:42Z","timestamp":1764183882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A spatiotemporal hypergraph self-attention neural networks framework for the identification and pharmacological efficacy assessment of Parkinson\u2019s disease motor symptoms"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiaochen","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"jun Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"1187_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: mechanisms and models. Neuron 39, 889\u2013909, https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3 (2003).","journal-title":"Neuron"},{"key":"1187_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","volume":"6","author":"JM Shulman","year":"2011","unstructured":"Shulman, J. M., De Jager, P. L. & Feany, M. B. Parkinson\u2019s disease: genetics and pathogenesis. Annu. Rev. Pathol. 6, 193\u2013222, https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130242 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"1187_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376, https:\/\/doi.org\/10.1136\/jnnp.2007.131045 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1187_CR4","doi-asserted-by":"publisher","unstructured":"Yasuhara, T. Neurobiology research in Parkinson\u2019s disease. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21030793 (2020).","DOI":"10.3390\/ijms21030793"},{"key":"1187_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912, https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"key":"1187_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0140-6736(71)92226-4","volume":"297","author":"A Barbeau","year":"1971","unstructured":"Barbeau, A. Long-term side-effects of levodopa. Lancet 297, 395, https:\/\/doi.org\/10.1016\/S0140-6736(71)92226-4 (1971).","journal-title":"Lancet"},{"key":"1187_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/mds.27216","volume":"33","author":"CW Olanow","year":"2018","unstructured":"Olanow, C. W. & Stocchi, F. Levodopa: a new look at an old friend. Mov. Disord. 33, 859\u2013866, https:\/\/doi.org\/10.1002\/mds.27216 (2018).","journal-title":"Mov. Disord."},{"key":"1187_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/pr.111.005678","volume":"65","author":"P Huot","year":"2013","unstructured":"Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H. & Brotchie, J. M. The Pharmacology of l-DOPA-induced dyskinesia in Parkinson\u2019s disease. Pharmacol. Rev. 65, 171\u2013222, https:\/\/doi.org\/10.1124\/pr.111.005678 (2013).","journal-title":"Pharmacol. Rev."},{"key":"1187_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.25364","volume":"84","author":"AJ Espay","year":"2018","unstructured":"Espay, A. J. et al. Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts. Ann. Neurol. 84, 797\u2013811, https:\/\/doi.org\/10.1002\/ana.25364 (2018).","journal-title":"Ann. Neurol."},{"key":"1187_CR10","doi-asserted-by":"publisher","unstructured":"Kwon, D. K., Kwatra, M., Wang, J. & Ko, H. S. Levodopa-induced dyskinesia in Parkinson\u2019s disease: pathogenesis and emerging treatment strategies. Cells 11, https:\/\/doi.org\/10.3390\/cells11233736 (2022).","DOI":"10.3390\/cells11233736"},{"key":"1187_CR11","doi-asserted-by":"publisher","first-page":"Ns20210026","DOI":"10.1042\/ns20210026","volume":"5","author":"J Lama","year":"2021","unstructured":"Lama, J., Buhidma, Y., Fletcher, E. J. R. & Duty, S. Animal models of Parkinson\u2019s disease: a guide to selecting the optimal model for your research. Neuronal Signal 5, Ns20210026, https:\/\/doi.org\/10.1042\/ns20210026 (2021).","journal-title":"Neuronal Signal"},{"key":"1187_CR12","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1523\/jneurosci.0267-20.2020","volume":"41","author":"I Dwi Wahyu","year":"2021","unstructured":"Dwi Wahyu, I., Chiken, S., Hasegawa, T., Sano, H. & Nambu, A. Abnormal cortico-basal ganglia neurotransmission in a mouse model of l-DOPA-induced dyskinesia. J. Neurosci. 41, 2668\u20132683, https:\/\/doi.org\/10.1523\/jneurosci.0267-20.2020 (2021).","journal-title":"J. Neurosci."},{"key":"1187_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainresbull.2004.10.011","volume":"68","author":"C Monville","year":"2005","unstructured":"Monville, C., Torres, E. M. & Dunnett, S. B. Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists. Brain Res. Bull. 68, 16\u201323, https:\/\/doi.org\/10.1016\/j.brainresbull.2004.10.011 (2005).","journal-title":"Brain Res. Bull."},{"key":"1187_CR14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1439-0310.2007.01406.x","volume":"113","author":"DM Marsh","year":"2007","unstructured":"Marsh, D. M. & Hanlon, T. J. Seeing what we want to see: confirmation bias in animal behavior research. Ethology 113, 1089\u20131098 (2007).","journal-title":"Ethology"},{"key":"1187_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fneur.2019.01016","volume":"10","author":"Q Peng","year":"2019","unstructured":"Peng, Q. et al. The rodent models of dyskinesia and their behavioral assessment. Front. Neurol. 10, 1016, https:\/\/doi.org\/10.3389\/fneur.2019.01016 (2019).","journal-title":"Front. Neurol."},{"key":"1187_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s42003-024-06786-2","volume":"7","author":"K Mimura","year":"2024","unstructured":"Mimura, K. et al. Unsupervised decomposition of natural monkey behavior into a sequence of motion motifs. Commun. Biol. 7, 1080, https:\/\/doi.org\/10.1038\/s42003-024-06786-2 (2024).","journal-title":"Commun. Biol."},{"key":"1187_CR17","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/1365-2656.13932","volume":"92","author":"C Wiltshire","year":"2023","unstructured":"Wiltshire, C. et al. DeepWild: application of the pose estimation tool DeepLabCut for behaviour tracking in wild chimpanzees and bonobos. J. Anim. Ecol. 92, 1560\u20131574, https:\/\/doi.org\/10.1111\/1365-2656.13932 (2023).","journal-title":"J. Anim. Ecol."},{"key":"1187_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02481-8","volume":"13","author":"YT Tseng","year":"2023","unstructured":"Tseng, Y. T. et al. Systematic evaluation of a predator stress model of depression in mice using a hierarchical 3D-motion learning framework. Transl. Psychiatry 13, 178. https:\/\/doi.org\/10.1038\/s41398-023-02481-8 (2023).","journal-title":"Transl. Psychiatry"},{"key":"1187_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s12264-024-01237-8","volume":"40","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Mapping the behavioral signatures of Shank3b mice in both sexes. Neurosci. Bull. 40, 1299\u20131314, https:\/\/doi.org\/10.1007\/s12264-024-01237-8 (2024).","journal-title":"Neurosci. Bull."},{"key":"1187_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1064","volume":"1","author":"H Jhuang","year":"2010","unstructured":"Jhuang, H. et al. Automated home-cage behavioural phenotyping of mice. Nat. Commun. 1, 68. https:\/\/doi.org\/10.1038\/ncomms1064 (2010).","journal-title":"Nat. Commun."},{"key":"1187_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22970-y","volume":"12","author":"K Huang","year":"2021","unstructured":"Huang, K. et al. A hierarchical 3D-motion learning framework for animal spontaneous behavior mapping. Nat. Commun. 12, 2784. https:\/\/doi.org\/10.1038\/s41467-021-22970-y (2021).","journal-title":"Nat. Commun."},{"key":"1187_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nmeth.2281","volume":"10","author":"M Kabra","year":"2013","unstructured":"Kabra, M., Robie, A. A., Rivera-Alba, M., Branson, S. & Branson, K. JAABA: interactive machine learning for automatic annotation of animal behavior. Nat. Methods 10, 64\u201367, https:\/\/doi.org\/10.1038\/nmeth.2281 (2013).","journal-title":"Nat. Methods"},{"key":"1187_CR23","doi-asserted-by":"crossref","unstructured":"Wang, S. H. et al. Tracking the 3D position and orientation of flying swarms with learned kinematic pattern using LSTM network. IEEE International Conference on Multimedia and Expo (ICME), pp. 1225-1230, https:\/\/doi.ieeecomputersociety.org\/10.1109\/ICME.2017.8019406 (2017).","DOI":"10.1109\/ICME.2017.8019406"},{"key":"1187_CR24","doi-asserted-by":"crossref","unstructured":"Yin, C., Liu, X., Zhang, X., Wang, S. & Su, H. Long 3D-POT: a long-term 3D drosophila-tracking method for position and orientation with self-attention weighted particle filters. Appl. Sci. 14, 6047 (2024).","DOI":"10.3390\/app14146047"},{"key":"1187_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91674-w","volume":"15","author":"Q Yang","year":"2025","unstructured":"Yang, Q. et al. Reynolds rules in swarm fly behavior based on KAN transformer tracking method. Sci. Rep. 15, 6982. https:\/\/doi.org\/10.1038\/s41598-025-91674-w (2025).","journal-title":"Sci. Rep."},{"key":"1187_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41593-020-00706-3","volume":"23","author":"AB Wiltschko","year":"2020","unstructured":"Wiltschko, A. B. et al. Revealing the structure of pharmacobehavioral space through motion sequencing. Nat. Neurosci. 23, 1433\u20131443, https:\/\/doi.org\/10.1038\/s41593-020-00706-3 (2020).","journal-title":"Nat. Neurosci."},{"key":"1187_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis, A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat. Neurosci. 21, 1281\u20131289, https:\/\/doi.org\/10.1038\/s41593-018-0209-y (2018).","journal-title":"Nat. Neurosci."},{"key":"1187_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2019.108352","volume":"326","author":"P Ravbar","year":"2019","unstructured":"Ravbar, P., Branson, K. & Simpson, J. H. An automatic behavior recognition system classifies animal behaviors using movements and their temporal context. J. Neurosci. Methods 326, 108352. https:\/\/doi.org\/10.1016\/j.jneumeth.2019.108352 (2019).","journal-title":"J. Neurosci. Methods"},{"key":"1187_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.applanim.2022.105594","volume":"249","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Automatically recognizing four-legged animal behaviors to enhance welfare using spatial temporal graph convolutional networks. Appl. Anim. Behav. Sci. 249, 105594. https:\/\/doi.org\/10.1016\/j.applanim.2022.105594 (2022).","journal-title":"Appl. Anim. Behav. Sci."},{"key":"1187_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","volume":"16","author":"M Lundblad","year":"2004","unstructured":"Lundblad, M., Picconi, B., Lindgren, H. & Cenci, M. A. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 16, 110\u2013123, https:\/\/doi.org\/10.1016\/j.nbd.2004.01.007 (2004).","journal-title":"Neurobiol. Dis."},{"key":"1187_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","volume":"194","author":"M Lundblad","year":"2005","unstructured":"Lundblad, M. et al. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Exp. Neurol. 194, 66\u201375, https:\/\/doi.org\/10.1016\/j.expneurol.2005.02.002 (2005).","journal-title":"Exp. Neurol."},{"key":"1187_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12264-021-00778-6","volume":"38","author":"Y Han","year":"2022","unstructured":"Han, Y. et al. MouseVenue3D: a markerless three-dimension behavioral tracking system for matching two-photon brain imaging in free-moving mice. Neurosci. Bull. 38, 303\u2013317, https:\/\/doi.org\/10.1007\/s12264-021-00778-6 (2022).","journal-title":"Neurosci. Bull."},{"key":"1187_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucom.2025.131004","volume":"651","author":"K-A Phu","year":"2025","unstructured":"Phu, K.-A., Hoang, V.-D. & Le, V.-T. -L. Predicting occluded skeletal joints via tracking-based feature extraction. Neurocomputing 651, 131004. https:\/\/doi.org\/10.1016\/j.neucom.2025.131004 (2025).","journal-title":"Neurocomputing"},{"key":"1187_CR34","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","volume":"96","author":"M Carta","year":"2006","unstructured":"Carta, M. et al. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. J. Neurochem. 96, 1718\u20131727, https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03696.x (2006).","journal-title":"J. Neurochem."},{"key":"1187_CR35","doi-asserted-by":"publisher","unstructured":"Caulfield, M. E., Stancati, J. A. & Steece-Collier, K. Induction and assessment of levodopa-induced dyskinesias in a rat model of Parkinson\u2019s disease. J. Vis. Exp. https:\/\/doi.org\/10.3791\/62970 (2021).","DOI":"10.3791\/62970"},{"key":"1187_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0006-8993(79)90269-5","volume":"167","author":"B Siegfried","year":"1979","unstructured":"Siegfried, B. & Bures, J. Conditioning compensates the neglect due to unilateral 6-OHDA lesions of substantia nigra in rats. Brain Res. 167, 139\u2013155, https:\/\/doi.org\/10.1016\/0006-8993(79)90269-5 (1979).","journal-title":"Brain Res."},{"key":"1187_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1469-7580.2000.19640519.x","volume":"196","author":"AR Crossman","year":"2000","unstructured":"Crossman, A. R. Functional anatomy of movement disorders. J. Anat. 196, 519\u2013525, https:\/\/doi.org\/10.1046\/j.1469-7580.2000.19640519.x (2000).","journal-title":"J. Anat."},{"key":"1187_CR38","unstructured":"Zhou, Y. et al. Hypergraph transformer for skeleton-based action recognition. Preprint at https:\/\/arxiv.org\/abs\/2211.09590 (2022)."},{"key":"1187_CR39","doi-asserted-by":"publisher","unstructured":"Yan, S. Xiong, Y. & Lin, D. Spatial temporal graph convolutional networks for skeleton-based action recognition. In Proceedings of the AAAI conference on artificial intelligence, https:\/\/doi.org\/10.1609\/aaai.v32i1.12328 (2018).","DOI":"10.1609\/aaai.v32i1.12328"},{"key":"1187_CR40","doi-asserted-by":"publisher","unstructured":"Zhou, Y. et al. BlockGCN: Redefine Topology Awareness for Skeleton-Based Action Recognition. IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR). 2049\u20132058, https:\/\/doi.org\/10.1109\/CVPR52733.2024.00200 (2024).","DOI":"10.1109\/CVPR52733.2024.00200"},{"key":"1187_CR41","doi-asserted-by":"publisher","unstructured":"Rascol, O. & Fabre, N. Dyskinesia: L-dopa-induced and tardive dyskinesia. Clin. Neuropharmacol. 24, 313\u2013323, https:\/\/doi.org\/10.1097\/00002826-200111000-00002 (2001).","DOI":"10.1097\/00002826-200111000-00002"},{"key":"1187_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1212\/01.wnl.0000110317.52453.6c","volume":"62","author":"F Durif","year":"2004","unstructured":"Durif, F. et al. Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. Neurology 62, 381\u2013388, https:\/\/doi.org\/10.1212\/01.wnl.0000110317.52453.6c (2004).","journal-title":"Neurology"},{"key":"1187_CR43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s40263-014-0205-z","volume":"28","author":"E Schaeffer","year":"2014","unstructured":"Schaeffer, E., Pilotto, A. & Berg, D. Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson\u2019s disease. CNS Drugs 28, 1155\u20131184, https:\/\/doi.org\/10.1007\/s40263-014-0205-z (2014).","journal-title":"CNS Drugs"},{"key":"1187_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","volume":"132","author":"MF Bastide","year":"2015","unstructured":"Bastide, M. F. et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog. Neurobiol. 132, 96\u2013168, https:\/\/doi.org\/10.1016\/j.pneurobio.2015.07.002 (2015).","journal-title":"Prog. Neurobiol."},{"key":"1187_CR45","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox, S. H. et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov. Disord. 33, 1248\u20131266, https:\/\/doi.org\/10.1002\/mds.27372 (2018).","journal-title":"Mov. Disord."},{"key":"1187_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0304-3940(87)90409-5","volume":"81","author":"E Galarraga","year":"1987","unstructured":"Galarraga, E., Bargas, J., Mart\u00ednez-Fong, D. & Aceves, J. Spontaneous synaptic potentials in dopamine-denervated neostriatal neurons. Neurosci. Lett. 81, 351\u2013355, https:\/\/doi.org\/10.1016\/0304-3940(87)90409-5 (1987).","journal-title":"Neurosci. Lett."},{"key":"1187_CR47","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1460-9568.1996.tb01228.x","volume":"8","author":"CG Parsons","year":"1996","unstructured":"Parsons, C. G., Panchenko, V. A., Pinchenko, V. O., Tsyndrenko, A. Y. & Krishtal, O. A. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur. J. Neurosci. 8, 446\u2013454, https:\/\/doi.org\/10.1111\/j.1460-9568.1996.tb01228.x (1996).","journal-title":"Eur. J. Neurosci."},{"key":"1187_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1124\/jpet.118.247650","volume":"367","author":"EF Brigham","year":"2018","unstructured":"Brigham, E. F. et al. Pharmacokinetic\/pharmacodynamic correlation analysis of amantadine for levodopa-induced dyskinesia. J. Pharm. Exp. Ther. 367, 373\u2013381, https:\/\/doi.org\/10.1124\/jpet.118.247650 (2018).","journal-title":"J. Pharm. Exp. Ther."},{"key":"1187_CR49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad, M. et al. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur. J. Neurosci. 15, 120\u2013132, https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01843.x (2002).","journal-title":"Eur. J. Neurosci."},{"key":"1187_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.27337","volume":"33","author":"MA Cenci","year":"2018","unstructured":"Cenci, M. A. & Crossman, A. R. Animal models of l-dopa-induced dyskinesia in Parkinson\u2019s disease. Mov. Disord. 33, 889\u2013899, https:\/\/doi.org\/10.1002\/mds.27337 (2018).","journal-title":"Mov. Disord."},{"key":"1187_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41531-022-00291-1","volume":"8","author":"RA Hauser","year":"2022","unstructured":"Hauser, R. A., Lytle, J., Formella, A. E. & Tanner, C. M. Amantadine delayed release\/extended release capsules significantly reduce OFF time in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 29, https:\/\/doi.org\/10.1038\/s41531-022-00291-1 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1187_CR52","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(21)00249-0","volume":"20","author":"O Rascol","year":"2021","unstructured":"Rascol, O., Fabbri, M. & Poewe, W. Amantadine in the treatment of Parkinson\u2019s disease and other movement disorders. Lancet Neurol. 20, 1048\u20131056, https:\/\/doi.org\/10.1016\/S1474-4422(21)00249-0 (2021).","journal-title":"Lancet Neurol."},{"key":"1187_CR53","doi-asserted-by":"publisher","first-page":"e15298","DOI":"10.1371\/journal.pone.0015298","volume":"5","author":"H Sawada","year":"2010","unstructured":"Sawada, H. et al. Amantadine for dyskinesias in Parkinson\u2019s disease: a randomized controlled trial. PLoS One 5, e15298, https:\/\/doi.org\/10.1371\/journal.pone.0015298 (2010).","journal-title":"PLoS One"},{"key":"1187_CR54","first-page":"617","volume":"81","author":"J Muench","year":"2010","unstructured":"Muench, J. & Hamer, A. M. Adverse effects of antipsychotic medications. Am. Fam. Physician 81, 617\u2013622 (2010).","journal-title":"Am. Fam. Physician"},{"key":"1187_CR55","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/schbul\/sbae065","volume":"51","author":"PA Lind","year":"2025","unstructured":"Lind, P. A., Parker, R. K., Northwood, K., Siskind, D. J. & Medland, S. E. Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: the ClozaGene study. Schizophr. Bull. 51, 458\u2013469, https:\/\/doi.org\/10.1093\/schbul\/sbae065 (2025).","journal-title":"Schizophr. Bull."},{"key":"1187_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1185\/0300799039117069","volume":"17","author":"M Naheed","year":"2001","unstructured":"Naheed, M. & Green, B. Focus on clozapine. Curr. Med. Res. Opin. 17, 223\u2013229, https:\/\/doi.org\/10.1185\/0300799039117069 (2001).","journal-title":"Curr. Med. Res. Opin."},{"key":"1187_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adc9669","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Monitoring gait at home with radio waves in Parkinson\u2019s disease: A marker of severity, progression, and medication response. Sci. Transl. Med 14, eadc9669. https:\/\/doi.org\/10.1126\/scitranslmed.adc9669 (2022).","journal-title":"Sci. Transl. Med"},{"key":"1187_CR58","doi-asserted-by":"publisher","DOI":"10.1177\/20552076231176653","volume":"9","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Kinect-based objective evaluation of bradykinesia in patients with Parkinson\u2019s disease. Digit Health 9, 20552076231176653. https:\/\/doi.org\/10.1177\/20552076231176653 (2023).","journal-title":"Digit Health"},{"key":"1187_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe, W. Non-motor symptoms in Parkinson\u2019s disease. Eur. J. Neurol. 15, 14\u201320, https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02056.x (2008).","journal-title":"Eur. J. Neurol."},{"key":"1187_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47, https:\/\/doi.org\/10.1038\/s41572-021-00280-3 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1187_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/bs.irn.2023.11.001","volume":"174","author":"L Batzu","year":"2024","unstructured":"Batzu, L., Podlewska, A., Gibson, L., Chaudhuri, K. R. & Aarsland, D. A general clinical overview of the non-motor symptoms in Parkinson\u2019s disease: neuropsychiatric symptoms. Int. Rev. Neurobiol. 174, 59\u201397, https:\/\/doi.org\/10.1016\/bs.irn.2023.11.001 (2024).","journal-title":"Int. Rev. Neurobiol."},{"key":"1187_CR62","doi-asserted-by":"publisher","unstructured":"da Concei\u00e7\u00e3o, F. S., Ngo-Abdalla, S., Houzel, J. C. & Rehen, S. K. Murine model for Parkinson\u2019s disease: from 6-OH dopamine lesion to behavioral test. J. Vis. Exp. https:\/\/doi.org\/10.3791\/1376 (2010).","DOI":"10.3791\/1376"},{"key":"1187_CR63","doi-asserted-by":"publisher","unstructured":"Cenci, M. A. & Lundblad, M. Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson\u2019s disease in rats and mice. Curr. Protoc. Neurosci. Chapter 9, Unit 9.25, https:\/\/doi.org\/10.1002\/0471142301.ns0925s41 (2007).","DOI":"10.1002\/0471142301.ns0925s41"},{"key":"1187_CR64","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.21105\/joss.01849","volume":"5","author":"S Sheshadri","year":"2020","unstructured":"Sheshadri, S., Dann, B., Hueser, T. & Scherberger, H. 3D reconstruction toolbox for behavior tracked with multiple cameras. J. Open Source Softw. 5, 1849 (2020).","journal-title":"J. Open Source Softw."},{"key":"1187_CR65","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.neuron.2023.02.003","volume":"111","author":"T Gschwind","year":"2023","unstructured":"Gschwind, T. et al. Hidden behavioral fingerprints in epilepsy. Neuron 111, 1440\u20131452.e1445, https:\/\/doi.org\/10.1016\/j.neuron.2023.02.003 (2023).","journal-title":"Neuron"},{"key":"1187_CR66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nbd.2016.09.001","volume":"96","author":"I Sebastianutto","year":"2016","unstructured":"Sebastianutto, I., Maslava, N., Hopkins, C. R. & Cenci, M. A. Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists. Neurobiol. Dis. 96, 156\u2013170, https:\/\/doi.org\/10.1016\/j.nbd.2016.09.001 (2016).","journal-title":"Neurobiol. Dis."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01187-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01187-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01187-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T19:04:43Z","timestamp":1764183883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01187-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01187-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}